Ivermectin vs. Merck's New Antiviral, MolnupiravirBased on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.Dr. Joseph MercolaOct 25, 2021∙ Paid4ShareContinue reading this post for free, courtesy of Dr. Joseph Mercola.Claim my free postOr purchase a paid subscription.
